Henry Schein, Inc. (HSIC) EV/EBITDA Ratio: 12.72x
Is Henry Schein, Inc.’s EV/EBITDA ratio high or low?
Henry Schein, Inc.'s EV/EBITDA ratio of 12.72x is in line with its 5-year average of 12.52x, around the middle of its 5-year range (9.29x–16.29x).
As of Tuesday, June 23, 2026. 2.64% above its 12-month average of 12.39x.
HSIC EV/EBITDA Ratio Chart
HSIC Average EV/EBITDA Ratio Chart
HSIC Current vs Average EV/EBITDA Ratio Chart
HSIC EV/EBITDA Ratio Metrics
EV/EBITDA RATIO
12.72x
EV/EBITDA RATIO AVG TTM
12.39x
EV/EBITDA RATIO AVG 3Y
12.93x
EV/EBITDA RATIO AVG 5Y
12.48x
EV/EBITDA RATIO AVG 10Y
12.50x
EV/EBITDA RATIO AVG 15Y
11.62x
EV/EBITDA RATIO AVG 20Y
10.91x
CURRENT VS TTM AVG
+2.64%
CURRENT VS 3Y AVG
-1.65%
CURRENT VS 5Y AVG
+1.94%
CURRENT VS 10Y AVG
+1.78%
CURRENT VS 15Y AVG
+9.47%
CURRENT VS 20Y AVG
+16.55%
HSIC Competitors' EV/EBITDA Ratio
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Henry Schein, Inc. (HSIC) | $8.96B | 12.72x | 12.39x | 12.93x | 12.48x |
| Charles River Laboratories International, Inc. (CRL)vs › | $8.75B | 40.45x | 24.92x | 17.56x | 18.54x |
| Tempus AI, Inc. (TEM)vs › | $8.35B | N/A | N/A | N/A | N/A |
| Baxter International Inc. (BAX)vs › | $10.15B | 24.11x | 20.35x | 19.16x | 19.13x |
| Oscar Health, Inc. (OSCR)vs › | $7.63B | 261.91x | 102.45x | 134.25x | 134.25x |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $7.60B | 17.99x | 12.07x | 61.22x | 33.01x |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | N/A | 21.34x | 19.40x | 19.09x |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.48B | 285.09x | 80.42x | 129.53x | 129.53x |
| Revvity, Inc. (RVTY)vs › | $11.05B | 17.56x | 17.10x | 19.86x | 18.24x |
| Align Technology, Inc. (ALGN)vs › | $12.44B | 12.64x | 13.06x | 20.16x | 25.78x |
EV/EBITDA vs. its own history
At 12.7, EV/EBITDA is richer than usual, sitting higher than 76% of its 20-year history.
20-year low
4.8
median
11.4
20-year high
16.3
Henry Schein, Inc. EV/EBITDA Ratio Formula & Definition
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Henry Schein, Inc. EV/EBITDA Ratio FAQ
- What is the EV/EBITDA ratio for Henry Schein, Inc. (HSIC)?
- The EV/EBITDA ratio for HSIC stock is 12.72x.
- Is Henry Schein, Inc.'s EV/EBITDA ratio high or low?
- Henry Schein, Inc.'s EV/EBITDA ratio of 12.72x is in line with its 5-year average of 12.52x, around the middle of its 5-year range (9.29x–16.29x).
- What is the TTM average EV/EBITDA ratio for Henry Schein, Inc. (HSIC)?
- The TTM average EV/EBITDA ratio for HSIC stock is 12.39x.
- What is the 3Y average EV/EBITDA ratio for Henry Schein, Inc. (HSIC)?
- The 3Y average EV/EBITDA ratio for HSIC stock is 12.93x.
- What is the 5Y average EV/EBITDA ratio for Henry Schein, Inc. (HSIC)?
- The 5Y average EV/EBITDA ratio for HSIC stock is 12.48x.
- What is the 10Y average EV/EBITDA ratio for Henry Schein, Inc. (HSIC)?
- The 10Y average EV/EBITDA ratio for HSIC stock is 12.50x.
- What is the 15Y average EV/EBITDA ratio for Henry Schein, Inc. (HSIC)?
- The 15Y average EV/EBITDA ratio for HSIC stock is 11.62x.
- What is the 20Y average EV/EBITDA ratio for Henry Schein, Inc. (HSIC)?
- The 20Y average EV/EBITDA ratio for HSIC stock is 10.91x.
Henry Schein, Inc. EV/EBITDA Ratio History
| DATE | EV/EBITDA RATIO |
|---|---|
| 2026-06-22 | 12.72x |
| 2026-06-18 | 12.86x |
| 2026-06-17 | 12.87x |
| 2026-06-16 | 13.01x |
| 2026-06-15 | 13.00x |
| 2026-06-12 | 13.01x |
| 2026-06-11 | 12.90x |
| 2026-06-10 | 12.74x |
| 2026-06-09 | 12.87x |
| 2026-06-08 | 12.64x |
| 2026-06-05 | 12.57x |
| 2026-06-04 | 12.44x |
| 2026-06-03 | 12.38x |
| 2026-06-02 | 12.41x |
| 2026-06-01 | 12.45x |
| 2026-05-29 | 12.47x |
| 2026-05-28 | 12.44x |
| 2026-05-27 | 12.37x |
| 2026-05-26 | 12.16x |
| 2026-05-22 | 12.20x |
| 2026-05-21 | 12.12x |
| 2026-05-20 | 12.09x |
| 2026-05-19 | 12.05x |
| 2026-05-18 | 12.02x |
| 2026-05-15 | 12.03x |
| 2026-05-14 | 12.01x |
| 2026-05-13 | 11.65x |
| 2026-05-12 | 11.64x |
| 2026-05-11 | 11.59x |
| 2026-05-08 | 11.81x |
| 2026-05-07 | 11.77x |
| 2026-05-06 | 11.99x |
| 2026-05-05 | 12.22x |
| 2026-05-04 | 12.07x |
| 2026-05-01 | 12.29x |
| 2026-04-30 | 12.37x |
| 2026-04-29 | 12.28x |
| 2026-04-28 | 12.55x |
| 2026-04-27 | 12.68x |
| 2026-04-24 | 12.72x |
| 2026-04-23 | 12.80x |
| 2026-04-22 | 12.79x |
| 2026-04-21 | 12.87x |
| 2026-04-20 | 12.91x |
| 2026-04-17 | 12.87x |
| 2026-04-16 | 12.68x |
| 2026-04-15 | 12.71x |
| 2026-04-14 | 12.68x |
| 2026-04-13 | 12.54x |
| 2026-04-10 | 12.46x |
| 2026-04-09 | 12.49x |
| 2026-04-08 | 12.48x |
| 2026-04-07 | 12.28x |
| 2026-04-06 | 12.40x |
| 2026-04-02 | 12.29x |
| 2026-04-01 | 12.19x |
| 2026-03-31 | 12.26x |
| 2026-03-30 | 12.15x |
| 2026-03-27 | 12.08x |
| 2026-03-26 | 12.27x |
| 2026-03-25 | 12.33x |
| 2026-03-24 | 12.30x |
| 2026-03-23 | 12.35x |
| 2026-03-20 | 12.10x |
| 2026-03-19 | 12.14x |
| 2026-03-18 | 12.20x |
| 2026-03-17 | 12.40x |
| 2026-03-16 | 12.37x |
| 2026-03-13 | 12.49x |
| 2026-03-12 | 12.42x |
| 2026-03-11 | 12.60x |
| 2026-03-10 | 12.57x |
| 2026-03-09 | 12.79x |
| 2026-03-06 | 12.73x |
| 2026-03-05 | 13.03x |
| 2026-03-04 | 13.08x |
| 2026-03-03 | 13.04x |
| 2026-03-02 | 13.17x |
| 2026-02-27 | 13.29x |
| 2026-02-26 | 13.18x |
| 2026-02-25 | 13.24x |
| 2026-02-24 | 13.41x |
| 2026-02-23 | 13.32x |
| 2026-02-20 | 13.20x |
| 2026-02-19 | 12.86x |
| 2026-02-18 | 13.01x |
| 2026-02-17 | 12.91x |
| 2026-02-13 | 13.03x |
| 2026-02-12 | 13.06x |
| 2026-02-11 | 13.46x |
| 2026-02-10 | 13.38x |
| 2026-02-09 | 13.27x |
| 2026-02-06 | 13.22x |
| 2026-02-05 | 12.88x |
| 2026-02-04 | 12.67x |
| 2026-02-03 | 12.41x |
| 2026-02-02 | 12.67x |
| 2026-01-30 | 12.69x |
| 2026-01-29 | 12.55x |
| 2026-01-28 | 12.65x |
| 2026-01-27 | 12.87x |
| 2026-01-26 | 12.96x |
| 2026-01-23 | 12.91x |
| 2026-01-22 | 13.06x |
| 2026-01-21 | 13.12x |
| 2026-01-20 | 12.97x |
| 2026-01-16 | 13.25x |
| 2026-01-15 | 13.02x |
| 2026-01-14 | 12.79x |
| 2026-01-13 | 12.74x |
| 2026-01-12 | 12.77x |
| 2026-01-09 | 12.96x |
| 2026-01-08 | 13.13x |
| 2026-01-07 | 13.02x |
| 2026-01-06 | 13.07x |
| 2026-01-05 | 13.07x |
| 2026-01-02 | 12.86x |
| 2025-12-31 | 12.71x |
| 2025-12-30 | 12.81x |
| 2025-12-29 | 12.81x |
| 2025-12-26 | 12.77x |
| 2025-12-24 | 12.78x |
| 2025-12-23 | 12.82x |
| 2025-12-22 | 12.95x |
| 2025-12-19 | 12.93x |
| 2025-12-18 | 12.88x |
| 2025-12-17 | 12.83x |
| 2025-12-16 | 12.89x |
| 2025-12-15 | 12.93x |
| 2025-12-12 | 12.83x |
| 2025-12-11 | 12.79x |
| 2025-12-10 | 12.74x |
| 2025-12-09 | 12.57x |
| 2025-12-08 | 12.37x |
| 2025-12-05 | 12.46x |
| 2025-12-04 | 12.43x |
| 2025-12-03 | 12.37x |
| 2025-12-02 | 12.22x |
| 2025-12-01 | 12.40x |
| 2025-11-28 | 12.58x |
| 2025-11-26 | 12.67x |
| 2025-11-25 | 12.70x |
| 2025-11-24 | 12.57x |
| 2025-11-21 | 12.44x |
| 2025-11-20 | 12.16x |
| 2025-11-19 | 12.09x |
| 2025-11-18 | 12.17x |
| 2025-11-17 | 12.17x |
| 2025-11-14 | 12.19x |
| 2025-11-13 | 12.43x |
| 2025-11-12 | 12.37x |
| 2025-11-11 | 12.42x |
| 2025-11-10 | 12.39x |
| 2025-11-07 | 12.25x |
| 2025-11-06 | 12.03x |
| 2025-11-05 | 12.27x |
| 2025-11-04 | 12.22x |
| 2025-11-03 | 11.59x |
| 2025-10-31 | 11.41x |
| 2025-10-30 | 11.37x |
| 2025-10-29 | 11.30x |
| 2025-10-28 | 11.41x |
| 2025-10-27 | 11.45x |
| 2025-10-24 | 11.49x |
| 2025-10-23 | 11.46x |
| 2025-10-22 | 11.45x |
| 2025-10-21 | 11.54x |
| 2025-10-20 | 11.50x |
| 2025-10-17 | 11.38x |
| 2025-10-16 | 11.26x |
| 2025-10-15 | 11.41x |
| 2025-10-14 | 11.43x |
| 2025-10-13 | 11.38x |
| 2025-10-10 | 11.40x |
| 2025-10-09 | 11.58x |
| 2025-10-08 | 11.60x |
| 2025-10-07 | 11.62x |
| 2025-10-06 | 11.77x |
| 2025-10-03 | 11.90x |
| 2025-10-02 | 11.77x |
| 2025-10-01 | 11.71x |
| 2025-09-30 | 11.81x |
| 2025-09-29 | 11.77x |
| 2025-09-26 | 11.77x |
| 2025-09-25 | 11.72x |
| 2025-09-24 | 11.99x |
| 2025-09-23 | 12.18x |
| 2025-09-22 | 12.01x |
| 2025-09-19 | 12.00x |
| 2025-09-18 | 12.09x |
| 2025-09-17 | 11.94x |
| 2025-09-16 | 12.07x |
| 2025-09-15 | 12.12x |
| 2025-09-12 | 12.15x |
| 2025-09-11 | 12.22x |
| 2025-09-10 | 11.95x |
| 2025-09-09 | 11.98x |
| 2025-09-08 | 11.99x |
| 2025-09-05 | 12.20x |
| 2025-09-04 | 11.99x |
| 2025-09-03 | 11.91x |
| 2025-09-02 | 12.07x |
| 2025-08-29 | 12.22x |
| 2025-08-28 | 12.15x |
| 2025-08-27 | 12.15x |
| 2025-08-26 | 12.16x |
| 2025-08-25 | 12.08x |
| 2025-08-22 | 12.23x |
| 2025-08-21 | 12.05x |
| 2025-08-20 | 12.10x |
| 2025-08-19 | 12.06x |
| 2025-08-18 | 11.92x |
| 2025-08-15 | 12.00x |
| 2025-08-14 | 12.01x |
| 2025-08-13 | 12.15x |
| 2025-08-12 | 11.96x |
| 2025-08-11 | 11.78x |
| 2025-08-08 | 11.76x |
| 2025-08-07 | 11.75x |
| 2025-08-06 | 11.81x |
| 2025-08-05 | 11.62x |
| 2025-08-04 | 12.28x |
| 2025-08-01 | 12.02x |
| 2025-07-31 | 11.97x |
| 2025-07-30 | 12.22x |
| 2025-07-29 | 12.28x |
| 2025-07-28 | 12.34x |
| 2025-07-25 | 12.47x |
| 2025-07-24 | 12.62x |
| 2025-07-23 | 12.82x |
| 2025-07-22 | 12.56x |
| 2025-07-21 | 12.16x |
| 2025-07-18 | 12.16x |
| 2025-07-17 | 12.21x |
| 2025-07-16 | 12.19x |
| 2025-07-15 | 12.36x |
| 2025-07-14 | 12.37x |
| 2025-07-11 | 12.72x |
| 2025-07-10 | 12.87x |
| 2025-07-09 | 12.82x |
| 2025-07-08 | 12.79x |
| 2025-07-07 | 12.73x |
| 2025-07-03 | 12.88x |
| 2025-07-02 | 12.86x |
| 2025-07-01 | 12.86x |
| 2025-06-30 | 12.67x |
| 2025-06-27 | 12.70x |
| 2025-06-26 | 12.69x |
| 2025-06-25 | 12.64x |
| 2025-06-24 | 12.63x |
| 2025-06-23 | 12.52x |
| 2025-06-20 | 12.53x |
| 2025-06-18 | 12.42x |
| 2025-06-17 | 12.30x |
| 2025-06-16 | 12.38x |
| 2025-06-13 | 12.30x |
| 2025-06-12 | 12.42x |
| 2025-06-11 | 12.43x |
| 2025-06-10 | 12.46x |
| 2025-06-09 | 12.39x |
Showing the most recent 260 of 5,030 data points. The chart above shows the full history.
Related Metrics
About Henry Schein, Inc.
Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Andrea Albertini